BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3249874)

  • 1. [P.I.C.: the intracavernous injection of papaverine, a diagnostic test in impotence].
    Zbranca E
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):589-92. PubMed ID: 3249874
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role and practical application of a diagnostic test using papaverine in erection dysfunction].
    Henriet JP; Maiza D
    Phlebologie; 1990; 43(4):579-86. PubMed ID: 2093908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
    Martin-du Pan R
    Rev Med Suisse Romande; 1989 Apr; 109(4):291-8. PubMed ID: 2660216
    [No Abstract]   [Full Text] [Related]  

  • 4. [Investigation of intracavernous injection of papaverine for erectile impotence].
    Takimoto Y; Kawazoe K; Hosokawa H; Hamada T; Ono M; Aoki Y; Yasuoka S
    Hinyokika Kiyo; 1989 Jan; 35(1):71-6. PubMed ID: 2729023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of an erection using papaverine].
    Terek A; Sekei J; Getz F
    Urol Nefrol (Mosk); 1989; (3):69-71. PubMed ID: 2773185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can an intracavernous papaverine injection be used to diagnose arteriogenic impotence?
    Imagawa A; Kawanishi Y
    Hinyokika Kiyo; 1988 Jul; 34(7):1185-9. PubMed ID: 3177140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are intracavernous injections of drugs for impotence harmless?].
    Bondil P
    Acta Urol Belg; 1988; 56(2):202-10. PubMed ID: 3400526
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intracavernous injection of prostaglandin E1 as a diagnostic test in erectile dysfunction].
    Marín Lafuente JC; Sańchez Moreno Horencia M; Puy Figuero Echeverría M; Llarena Ibarguren R; Pertusa Peña C
    Arch Esp Urol; 1990; 43(6):661-3. PubMed ID: 2092621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracavernous injections: role in the diagnosis and therapy of problems in erection].
    Jardin A; Benoit G; Giuliano F
    Journ Annu Diabetol Hotel Dieu; 1993; ():359-74. PubMed ID: 8101244
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of Doppler studies following intracavernous injection of papaverine hydrochloride in the diagnosis of impotence of arterial origin].
    Sellam R; Laurian C; Franceschi C
    Acta Urol Belg; 1988; 56(2):252-64. PubMed ID: 3041770
    [No Abstract]   [Full Text] [Related]  

  • 11. [Corpus cavernosum injection treatment of erectile impotence].
    Lenk S; Schönherr G; Korner I
    Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study with intracavernous injection of prostaglandin E1 versus papaverine for the diagnostic assessment of erectile impotence.
    Wang CJ; Wu CC; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):585-90. PubMed ID: 1296038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence].
    Buvat J; Lemaire A; Marcolin G; Dehaene JL; Buvat-Herbaut M
    J Urol (Paris); 1986; 92(2):111-6. PubMed ID: 2876042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Plea for the use of facilitator drugs. 2. Diagnostic and therapeutic applications].
    Buvat J; Buvat-Herbaut M; Lemaire A; Marcolin G
    J Urol (Paris); 1989; 95(2):89-96. PubMed ID: 2567319
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between intracavernous papaverine injection, Doppler analysis and cavernosography in impotent patients.
    Sargin YS; Ozen HA; Başar I; Ergen A; Celebi I; Erol D; Koçal C; Remzi D
    Int Urol Nephrol; 1991; 23(5):489-93. PubMed ID: 1938248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracavernous injection of papaverine. Diagnostic value].
    Nguyen Hoang T; Guillé F; Dufeuil P; Lobel B
    Ann Urol (Paris); 1988; 22(1):54-6. PubMed ID: 3369846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current diagnostic-therapeutic trends in vasculogenic impotence].
    Giordanengo F; Bergamaschi E; Giuffrida GF; Cugnasca M
    Minerva Med; 1989 Aug; 80(8):861-4. PubMed ID: 2797485
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic erection program for the treatment of male impotence.
    Trapp JD
    South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.